Product NDC: | 24208-446 |
Proprietary Name: | Besivance |
Non Proprietary Name: | Besifloxacin |
Active Ingredient(s): | 6 mg/mL & nbsp; Besifloxacin |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 24208-446 |
Labeler Name: | Bausch & Lomb Incorporated |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022308 |
Marketing Category: | NDA |
Start Marketing Date: | 20090528 |
Package NDC: | 24208-446-05 |
Package Description: | 1 BOTTLE, DROPPER in 1 CARTON (24208-446-05) > 5 mL in 1 BOTTLE, DROPPER |
NDC Code | 24208-446-05 |
Proprietary Name | Besivance |
Package Description | 1 BOTTLE, DROPPER in 1 CARTON (24208-446-05) > 5 mL in 1 BOTTLE, DROPPER |
Product NDC | 24208-446 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Besifloxacin |
Dosage Form Name | SUSPENSION |
Route Name | OPHTHALMIC |
Start Marketing Date | 20090528 |
Marketing Category Name | NDA |
Labeler Name | Bausch & Lomb Incorporated |
Substance Name | BESIFLOXACIN |
Strength Number | 6 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |